The development of MDR TB is primarily due to the misuse or mismanagement of first-line anti-tuberculosis drugs. Inadequate or incomplete treatment courses allow Mycobacterium tuberculosis to mutate and develop resistance. This can occur when patients do not adhere to their treatment regimen or when doctors prescribe inappropriate treatments. Additionally, poor quality drugs and incorrect dosages contribute to the emergence of resistance.
